<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><span style="color:#231F20;">Plasma cell myeloma (previously referred to as multiple myeloma), is cancer affecting the plasma cells in the bone marrow.&nbsp;These abnormal plasma cells occur in increased numbers and produce abnormal non- functional immunoglobulins leading to impaired ability to fight infections in the patient affected, hyperviscosity and renal failure. In the bone marrow the increased plasma cells result in a reduction in normal blood cell production and erosion of bone with resultant peripheral blood cytopaenias,&nbsp;osteolytic&nbsp;lesions,&nbsp;pathological&nbsp;fractures&nbsp;and&nbsp;hypercalcaemia. The disease is commonest in the sixth decade and rare below the age of 40&nbsp;years.</span></p><h3>CAUSES</h3><ul><li>Unknown</li><li><strong>Potential precipitants</strong>:<ul><li>Chemicals e.g. dioxins, formaldehyde, and nitrobenzene found in solvents and cleaning agents</li><li>Ionizing radiation</li><li>Viruses e.g. Herpes Virus 8, Epstein-Barr, HIV,&nbsp;Hepatitis&nbsp;Virus</li></ul></li></ul><h3>SYMPTOMS</h3><ul><li>Bone pain</li><li>Easy&nbsp;fatiguability</li><li>Excessive weakness</li><li>Recurrent infections</li><li>Bony swellings</li></ul><h3>SIGNS</h3><ul><li>Pallor</li><li>Fever</li><li>Dehydration</li><li>Bony lumps</li><li>Paraplegia</li><li>Paresis</li><li>Renal Impairment</li><li>Unprovoked fractures</li></ul><h3>INVESTIGATIONS</h3><ul><li>FBC and blood film comment</li><li>ESR</li><li>Blood urea, electrolytes, creatinine</li><li>Plasma calcium levels</li><li>Serum uric acid</li><li>Bone marrow aspirate</li><li>Skeletal survey including skull X-ray</li><li>Serum protein levels</li><li>Serum protein electrophoresis</li><li>Urine Bence Jones protein</li></ul><h3>TREATMENT</h3><h3><strong>Treatment objectives</strong></h3><ul><li>To&nbsp;reduce the number of abnormal plasma cells to normal&nbsp;and reduce their rate of increase</li><li>To&nbsp;treat&nbsp;anaemia</li><li>To&nbsp;reduce bone&nbsp;pain</li><li>To&nbsp;manage pathological&nbsp;fracture</li><li>To&nbsp;improve or maintain good bone mineral&nbsp;density</li><li>To&nbsp;treat&nbsp;infections</li><li>To&nbsp;prevent and treat renal&nbsp;complications</li></ul><h3>Non-pharmacological treatment</h3><ul><li>Patients&nbsp;should drink&nbsp;at&nbsp;least&nbsp;3&nbsp;litres&nbsp;of&nbsp;fluid&nbsp;each&nbsp;day&nbsp;throughout&nbsp;the course of their disease</li><li>Physiotherapy</li><li>Orthopaedic&nbsp;supports</li></ul><h3>Pharmacological treatment</h3><p><span style="color:#231F20;"><strong>A.&nbsp;&nbsp;&nbsp;&nbsp; To&nbsp;reduce number of plasma cells and rate&nbsp;of&nbsp;increase</strong></span></p><p>Available at specialized centres only</p><h3><span style="color:#231F20;">B. To&nbsp;reduce bone&nbsp;pain</span></h3><p>Pain relief (avoid NSAIDS)</p><h3><span style="color:#231F20;">C. &nbsp;To&nbsp;treat&nbsp;anaemia</span></h3><p>Packed&nbsp;red&nbsp;cells&nbsp;transfusion&nbsp;and&nbsp;platelet&nbsp;transfusion&nbsp;when&nbsp;indicated</p><p><span style="color:#231F20;"><strong>D. To&nbsp;prevent and treat renal&nbsp;complications</strong></span></p><p>IV and oral fluids</p><p><span style="color:#231F20;"><strong>E. To&nbsp;mitigate tumour&nbsp;lysis</strong></span></p><p>Allopurinol to mitigate tumour lysis</p><p><span style="color:#231F20;"><strong>F. To treat&nbsp;infections</strong></span></p><p>(See appropriate section)</p><h3>REFERRAL CRITERIA</h3><p style="text-align:justify;"><span style="color:#231F20;">All patients suspected to have plasma cell myeloma should be referred to a haematologist at a specialised tertiary centre for further evaluation and definitive management. Subsequent follow-up can be done by a physician specialist with guidance from the haematologist.</span></p>
</body>
</html>
